Follow
Iris Tanaka
Iris Tanaka
Post-doctoral researcher, Istituto Italiano di Tecnologia, Center for Genomic Sciences
Verified email at iit.it - Homepage
Title
Cited by
Cited by
Year
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
I Tanaka, A Chakraborty, O Saulnier, C Benoit-Pilven, S Vacher, D Labiod, ...
Nucleic acids research 48 (5), 2676-2693, 2020
342020
Direct RNA sequencing for the study of synthesis, processing, and degradation of modified transcripts
M Furlan, I Tanaka, T Leonardi, S De Pretis, M Pelizzola
Frontiers in Genetics 11, 394, 2020
102020
Sulforadex targets breast cancer stem-like cells in patient-derived cells and xenograft tumors
BM Simões, D Alferez, R Eyre, K Spence, A Santiago-Gomez, I Tanaka, ...
Cancer Research 75 (15_Supplement), 2319-2319, 2015
32015
Depletion of Mettl3 in cholinergic neurons causes adult-onset neuromuscular degeneration
G Dermentzaki, M Furlan, I Tanaka, T Leonardi, P Rinchetti, PMS Passos, ...
Cell Reports 43 (4), 2024
2024
Intronic polyadenylation isoforms in the 5'part of genes constitute a source of microproteins and are involved in cell response to cisplatin
A DEVAUX, I TANAKA, M CADIX, A HENEMAN-MASUREL, S Michallet, ...
bioRxiv, 2023.12. 05.569446, 2023
2023
Régulation de l'épissage et de la polyadénylation alternatifs par les agents anti-cancéreux génotoxiques
I Tanaka
Université Paris-Saclay (ComUE), 2019
2019
Abstract PD2-02: SFX-01 targets Wnt signalling to inhibit stem-like cells in breast cancer patient-derived xenograft tumours
SJ Howell, BM Simoes, D Alferez, R Eyre, K Spence, A Santiago-Gómez, ...
Cancer Research 77 (4_Supplement), PD2-02-PD2-02, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–7